Diethylenetriamine pentaacetic acid derivative of toremifene and in vitro evaluation in human breast cancer cell line MCF-7

Cancer Biother Radiopharm. 2011 Feb;26(1):105-11. doi: 10.1089/cbr.2010.0860.

Abstract

Cytotoxic and apoptotic effects of toremifene-diethylenetriamine pentaacetic acid (TOR-DTPA), formed by conjugation of TOR and DTPA, on the MCF-7 cell line were evaluated. TOR-DTPA was synthesized and qualified via gas chromatography-mass spectrometry system, thin layer chromatography, and high performance liquid chromatography methods. To screen the biological properties of TOR-DTPA at determined concentrations, our ongoing effort was to evaluate apoptotic and cytotoxic effects on the MCF-7 cell line. Trypan blue dye exclusion test, XTT, ELISA, and TUNEL assays were utilized to evaluate cytotoxicity and apoptosis. TOR-DTPA has no cytotoxic and limited apoptotic effect on the MCF-7 cell line according to the results of in vitro studies. It is concluded that the lack of obvious apoptotic and cytotoxic effects allows the already proposed ligand, TOR-DTPA, to be improved as a novel hydrophilic ligand for breast imaging.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms / drug therapy*
  • Cell Line, Tumor
  • Drug Screening Assays, Antitumor
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Gas Chromatography-Mass Spectrometry
  • Humans
  • Ligands
  • Pentetic Acid / adverse effects
  • Pentetic Acid / analogs & derivatives*
  • Pentetic Acid / chemistry
  • Pentetic Acid / pharmacology*
  • Selective Estrogen Receptor Modulators / adverse effects
  • Selective Estrogen Receptor Modulators / chemistry
  • Selective Estrogen Receptor Modulators / pharmacology*
  • Toremifene / adverse effects
  • Toremifene / analogs & derivatives*
  • Toremifene / chemistry
  • Toremifene / pharmacology*

Substances

  • Ligands
  • Selective Estrogen Receptor Modulators
  • Pentetic Acid
  • Toremifene